Companies/US/APYX

APYX MEDICAL CORPORATION

Income flow

Annual
APYX 10-K Income StatementPeriod 2025-12-31Source 10-K
Surgical Aesthetics$45MOem$8MRevenue$53M+10% Y/YGross profit$33M+13% Y/YCost of revenue$20M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · USD
By activity
By activity$53M
  • Surgical Aesthetics$45M85.8%
  • Oem$8M14.2%
By geography
By geography$53M
  • United States$39M73.4%
  • Non-US$14M26.6%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).42.1MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).30.5M